Free Webinar — Psychedelic Autism: A Brief Intro and Q&A with...

atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a...

PT367 – Colorado Proposition 122 and the Decriminalization of Natural Medicines

Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs

Variants in 5-HT2A Receptor Gene Alter Psychedelic Pharmacology

Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University...

Psychedelic Bulletin #120: Beckley Psytech Acquires Eleusis; A Look at COMPASS’...

Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis...

Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s...

PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules

Load more